Search Within

David Hyman

  1. "2016"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (14)
Groups
  1. Department of Medicine (34)
  2. Early Drug Development Service (34)
  3. Solid Tumor Oncology Division (34)
  4. GSK Faculty (20)
  5. Epidemiology and Biostatistics (15)
  6. Human Oncology and Pathogenesis Program (15)

More Groups

People
  1. David Solit (12)
  2. Michael Berger (11)
  3. Ahmet Zehir (7)
  4. Alexander Drilon (7)
  5. Jose Baselga (7)
  6. Maria Arcila (7)

More People

Years
  1. 2016 (34)
Publications
  1. Journal of Clinical Oncology (13)
  2. Annals of Oncology (3)
  3. Blood (3)
  4. Clinical Cancer Research (2)
  5. European Journal of Cancer (2)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (4)
  4. American Society of Hematology (3)
  5. Elsevier Inc. (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (34)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and clinical characterization of gliosarcomas
    Meeting Abstract

    Wu, S.; Brennan, C.; Zahir, A.; Berger, M.; Solit, D.; Hyman, D.; Huse, J.; Rosenblum, M.; Omuro, A.
    Neurology (2016)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Serial next generation sequencing (NGS) of cell free DNA (cfDNA) and clonal evolution of AKT1 E17K mutant tumors: Analyses from patients (pts) enrolled on a phase I basket study of an AKT inhibitor (AZD5363)
    Meeting Abstract

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, S. D.; You, D.; Samoila, A.; Schiavon, G.; Li, B. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection
    Meeting Abstract

    Jordan, E.; Barron, D.; Schultz, N.; Chakravarty, D.; Kris, M. G.; Rudin, C. M.; Li, B. T.; Yu, H. A.; Drilon, A. E.; Rusch, V. W.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors
    Meeting Abstract

    Hyman, D. M.; Tran, B.; Jaime, J. C.; Garralda, E.; Machiels, J. P. H.; Schellens, J. H. M.; Bedard, P.; Campone, M.; Cassier, P.; Sarantopoulos, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Preliminary results from the first in human study of activin-A inhibitor, STM434, in patients with granulosa cell ovarian cancer and other advanced solid tumors
    Meeting Abstract

    Hyman, D. M.; Rasco, D. W.; Infante, J. R.; Liu, J. F.; Welkowsky, E.; Thai, D. L.; Haqq, C. M.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas
    Meeting Abstract

    Gounder, M. M.; Bauer, T. M.; Schwartz, G. K.; Masters, T.; Carvajal, R. D.; Song, S.; Kumar, P.; Gajee, R.; Zernovak, O.; Rosen, M. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save